Latest Reports

The "2025 India Ophthalmic Market Report" delivers a comprehensive analysis of India’s ophthalmic market, highlighting key trends, competitive dynamics, and factors shaping future growth. The report includes forecasts for disease prevalence, procedure volumes, and technology adoption across diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. 

Profiles of 30 leading competitors provide insight into product portfolios, strategic positioning, and market outlook. 

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Cataract Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Refractive Editions. These editions are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The Ophthalmic Market Trends: Quarterly US Glaucoma Editions deliver essential, data-driven insights into the US glaucoma surgery market. These reports, based on quarterly surveys of glaucoma surgeons, provide a comprehensive analysis of key metrics such as patient diagnoses, treatment regimens, medication usage, surgical procedure volumes, and emerging trends in MIGS, canal-based procedures, and investigational treatments. With in-depth trend analysis, full-year forecasts, and year-over-year comparisons, these editions equip you with the latest information on product adoption, market share, and treatment strategies, ensuring you make informed, strategic decisions in the glaucoma treatment landscape.

Our coverage of the US retina market includes a quarterly surveying process that targets and collects data from retina specialists. The resulting data are analyzed and presented in our Ophthalmic Market Trends: Quarterly US Retina Editions. These editions are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including retinal patient care, product use and market share, product adoption plans, and doctors’ evaluations of pharmaceuticals and surgical equipment.

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Market Scope’s "2025 Retinal Disease Model" delivers deep, country-level insight into the true scale of retinal disease worldwide, with detailed prevalence estimates and five-year forecasts by age group for every country with a population over one million.

Built on the latest clinical research and global demographic projections, this proprietary model provides a rigorous, forward-looking view of retinal disease—and can be customized by geography and disease category to match specific strategic needs. The model enables companies to quantify addressable patient populations, evaluate target markets for clinical- and commercial-stage products, and understand how disease volume and demographics are expected to evolve over time.

Market Scope’s "2025 Corneal Disease Model" delivers detailed, country-level insight into corneal disease prevalence worldwide, with age-specific estimates and five-year forecasts across nine corneal indications for every country with a population over one million.

Built on the latest clinical literature and global demographic projections, this proprietary model provides a consistent, forward-looking view of corneal disease prevalence. The model can be customized by geography and disease category to support strategic planning, including market sizing, evaluation of target populations for clinical- and commercial-stage products, and analysis of how corneal disease demographics are expected to evolve over time.

Market Scope’s “2025 Ophthalmic Diagnostic Equipment Survey Report” provides a data-driven snapshot of how United States ophthalmologists and optometrists are evaluating, purchasing, and using diagnostic technologies in today’s evolving clinical environment.  

Based on a nationwide online survey of 480 verified providers, the report delivers direct insight into capital investment priorities, technology adoption, and the growing influence of digital tools, AI, and data integration across ophthalmic practices.  

This survey report examines how and why purchasing decisions are made, what features and services matter most, how diagnostic budgets are changing, and where practices see value in next-generation technologies. Coverage spans core diagnostic categories as well as fast-growing areas such as artificial intelligence, interoperability, digital applications, and telehealth—offering both a current-state assessment and a forward-looking view of the diagnostic landscape. 

Survey questions were developed by Market Scope in collaboration with sponsoring companies, ensuring the data addresses the most commercially and strategically relevant issues facing diagnostic equipment manufacturers.  

The “2025 Cataract Pharmaceuticals Market Report” provides a comprehensive, data-driven market analysis of the drugs used before, during, and after cataract surgery in the United States and Western Europe. The report examines current utilization patterns and provides five-year forecasts for revenue by product category. 

Coverage includes antibiotics, anti-inflammatory agents, mydriatics/cycloplegics, pain management drugs, and intracameral formulations, along with a detailed look at fixed combinations, branded products, generics, and compounded alternatives. The report also explores evolving surgical practices, the growing role of intracameral injections, reimbursement dynamics, and the competitive pipeline shaping the future of cataract pharmaceuticals.